Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) EBT Margin: 2009-2025

Historic EBT Margin for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -30.01%.

  • Lifecore Biomedical's EBT Margin rose 1580.00% to -3.06% in Q2 2025 from the same period last year, while for May 2025 it was -30.01%, marking a year-over-year decrease of 3743.00%. This contributed to the annual value of -30.01% for FY2025, which is 3743.00% down from last year.
  • Lifecore Biomedical's EBT Margin amounted to -30.01% in FY2025, which was down 504.58% from 7.42% recorded in FY2024.
  • Lifecore Biomedical's 5-year EBT Margin high stood at 7.42% for FY2024, and its period low was -61.90% during FY2023.
  • Moreover, its 3-year median value for EBT Margin was -30.01% (2025), whereas its average is -28.17%.
  • In the last 5 years, Lifecore Biomedical's EBT Margin slumped by 4,331bps in 2023 and then soared by 6,932bps in 2024.
  • Lifecore Biomedical's EBT Margin (Yearly) stood at -29.53% in 2021, then skyrocketed by 1,094bps to -18.59% in 2022, then crashed by 4,331bps to -61.90% in 2023, then skyrocketed by 6,932bps to 7.42% in 2024, then crashed by 3,743bps to -30.01% in 2025.